95 related articles for article (PubMed ID: 29313429)
1. Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells.
Bayat H; Hossienzadeh S; Pourmaleki E; Ahani R; Rahimpour A
Prep Biochem Biotechnol; 2018 Feb; 48(2):160-164. PubMed ID: 29313429
[TBL] [Abstract][Full Text] [Related]
2. Expression of antibodies using single open reading frame (sORF) vector design: Demonstration of manufacturing feasibility.
Gion WR; Davis-Taber RA; Regier DA; Fung E; Medina L; Santora LC; Bose S; Ivanov AV; Perilli-Palmer BA; Chumsae CM; Matuck JG; Kunes YZ; Carson GR
MAbs; 2013; 5(4):595-607. PubMed ID: 23774760
[TBL] [Abstract][Full Text] [Related]
3. Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies.
Bolisetty P; Tremml G; Xu S; Khetan A
MAbs; 2020; 12(1):1763727. PubMed ID: 32449878
[TBL] [Abstract][Full Text] [Related]
4. Recombinant monoclonal antibody production in yeasts: Challenges and considerations.
Das PK; Sahoo A; Veeranki VD
Int J Biol Macromol; 2024 May; 266(Pt 2):131379. PubMed ID: 38580014
[TBL] [Abstract][Full Text] [Related]
5. Genomic barcoding for clonal diversity monitoring and control in cell-based complex antibody production.
Bauer N; Oberist C; Poth M; Stingele J; Popp O; Ausländer S
Sci Rep; 2024 Jun; 14(1):14587. PubMed ID: 38918509
[TBL] [Abstract][Full Text] [Related]
6. A systemic approach to identifying sequence frameworks that decrease mAb production in a transient Chinese hamster ovary cell expression system.
Szkodny AC; Lee KH
Biotechnol Prog; 2024 Apr; ():e3466. PubMed ID: 38607316
[TBL] [Abstract][Full Text] [Related]
7. Development of a 10 g/L process for a difficult-to-express multispecific antibody format using a holistic process development approach.
Peltret M; Vetsch P; Farvaque E; Mette R; Tsachaki M; Duarte L; Duret A; Vaxelaire E; Frank J; Moritz B; Aillerie C; Giovannini R; Bertschinger M
J Biotechnol; 2024 Jun; 389():30-42. PubMed ID: 38685416
[TBL] [Abstract][Full Text] [Related]
8. Multi-host expression system for recombinant production of challenging proteins.
Meyer S; Lorenz C; Baser B; Wördehoff M; Jäger V; van den Heuvel J
PLoS One; 2013; 8(7):e68674. PubMed ID: 23874717
[TBL] [Abstract][Full Text] [Related]
9. Combined approach of selective and accelerated cloning for microfluidic chip-based system increases clone specific productivity.
Desmurget C; Frentzel J; Strembitska A; Sobkowiak K; Perilleux A; Souquet J; Borth N; Douet J
Biotechnol J; 2024 May; 19(5):e2300488. PubMed ID: 38803036
[TBL] [Abstract][Full Text] [Related]
10. When will we have a clone? An industry perspective on the typical CLD timeline.
Clarke H; Mayer-Bartschmid A; Zheng C; Masterjohn E; Patel F; Moffat M; Wei Q; Liu R; Emmins R; Fischer S; Rieder S; Kelly T
Biotechnol Prog; 2024 Mar; ():e3449. PubMed ID: 38477447
[TBL] [Abstract][Full Text] [Related]
11. RNA-Seq Highlights High Clonal Variation in Monoclonal Antibody Producing CHO Cells.
Orellana CA; Marcellin E; Palfreyman RW; Munro TP; Gray PP; Nielsen LK
Biotechnol J; 2018 Mar; 13(3):e1700231. PubMed ID: 29316330
[TBL] [Abstract][Full Text] [Related]
12. Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content.
Kuwae S; Miyakawa I; Doi T
Cytotechnology; 2018 Jun; 70(3):939-948. PubMed ID: 29322349
[TBL] [Abstract][Full Text] [Related]
13. Glycoengineering in CHO Cells: Advances in Systems Biology.
Tejwani V; Andersen MR; Nam JH; Sharfstein ST
Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
[TBL] [Abstract][Full Text] [Related]
14. Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells.
Inwood S; Betenbaugh MJ; Shiloach J
Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29315258
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term effects on mAb-producing CHO cell lines after cryopreservation.
Subramanian J; Aulakh RPS; Grewal PS; Sanford M; Pynn AFJ; Yuk IH
Biotechnol Prog; 2018 Mar; 34(2):463-477. PubMed ID: 29314708
[TBL] [Abstract][Full Text] [Related]
16. Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell Lines and Subcloning.
Vcelar S; Melcher M; Auer N; Hrdina A; Puklowski A; Leisch F; Jadhav V; Wenger T; Baumann M; Borth N
Biotechnol J; 2018 Mar; 13(3):e1700495. PubMed ID: 29328552
[TBL] [Abstract][Full Text] [Related]
17. A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies.
Roy G; Martin T; Barnes A; Wang J; Jimenez RB; Rice M; Li L; Feng H; Zhang S; Chaerkady R; Wu H; Marelli M; Hatton D; Zhu J; Bowen MA
MAbs; 2018 Apr; 10(3):416-430. PubMed ID: 29400603
[TBL] [Abstract][Full Text] [Related]
18. Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients.
Pereira S; Kildegaard HF; Andersen MR
Biotechnol J; 2018 Mar; 13(3):e1700499. PubMed ID: 29393587
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apoptosis using exosomes in Chinese hamster ovary cell culture.
Han S; Rhee WJ
Biotechnol Bioeng; 2018 May; 115(5):1331-1339. PubMed ID: 29337363
[TBL] [Abstract][Full Text] [Related]
20. Real-time monitoring of antibody glycosylation site occupancy by in situ Raman spectroscopy during bioreactor CHO cell cultures.
Li MY; Ebel B; Paris C; Chauchard F; Guedon E; Marc A
Biotechnol Prog; 2018 Mar; 34(2):486-493. PubMed ID: 29314747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
